Global Biopharmaceutical and Biomedicine Market: Restraint
The major factors that hinder growth of the global biopharmaceutical and biomedicine market include high cost of biopharmaceutical and biomedicine products. Costs of biopharmaceutical and biomedicine products are quite high as these need research and development process, and their manufacturing is a very complex process, which needs highly skilled scientists. Such expensive biopharmaceutical products are not affordable to organizations in emerging economies such as India, China, etc. High cost of biopharmaceutical and biomedicine products is a major factor hindering its adoption. For instance, in India a vial of Avastin, a monoclonal antibody, costs between US$ 372.65 to US$ 402.46. High cost medicine is not affordable to everyone, hence, it is a major restraining factor for market growth.
Biopharmaceutical and Biomedicine Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients